openPR Logo
Press release

aspose.cloud Newsletter February 2019: Work with Cloud File Format REST APIs & SDKs

02-06-2019 12:22 PM CET | IT, New Media & Software

Press release from: Aspose

Aspose.Cloud Newsletter for February 2019 has now been published that highlights all the newly supported features offered in the recent releases. It also includes information about Cloud REST API and SDKs for working with Microsoft Visio Diagrams, Reordering multiple PowerPoint slides in one Cloud REST API call, Convert HTML to Markdown and MHTML formats in cloud applications and much more.

Cloud REST API and SDKs for working with Microsoft Visio Diagrams

Manipulate Visio files without Microsoft Visio installed. Aspose.Diagram offers cloud REST API and SDKs for .NET, Java, cURL, PHP, Python, Ruby and Node.js platforms to seamlessly create, edit and convert Visio file formats without needing Microsoft Visio. It supports working with native VSD/VSDX format as well as other popular Visio formats including VSS, VST, VSX, VTX, VDW, VDX, VSSX, VSTX, VSDM, VSSM and VSTM. Download Free Trial: https://dashboard.aspose.cloud/?utm_source=nl&utm_campaign=nl-feb19&utm_medium=link
Reordering multiple PowerPoint slides in one Cloud REST API call

Aspose.Slides Cloud REST API offers separate SDKs for .NET, Java, cURL, PHP and Node.js platforms to manipulate PowerPoint presentations. The latest version now supports reordering multiple slides in a presentation in one API call. Developers can also add slides in a presentation as well copying slides from other presentation or moving to other position. Read more details here: https://blog.aspose.cloud/2019/01/15/reorder-multiple-slides-in-one-api-call-using-aspose.slides-cloud-18.12/?utm_source=nl&utm_campaign=nl-feb19&utm_medium=link

Convert HTML to Markdown and MHTML formats in cloud applications

Aspose.HTML Cloud REST APIs and SDKs for popular platforms allow to dynamically manipulate HTML documents within cloud applications. The latest version supports converting HTML file to Markdown (Standard and GitLab Flavored Markdown) and MHTML formats. While converting HTML to MHTML – you can handle the resource depth level using maxDepth API parameter, scripts with javaScript API parameter, URLs with urlRestrict API parameter and use defaults API parameters for resources handling.

Collect a copy of Aspose Newsletter, February 2019 edition

- Collect the English version of this newsletter: https://blog.aspose.cloud/2019/02/01/working-with-cloud-file-format-rest-apis-and-sdks-aspose.cloud-newsletter-february-2019/

Aspose Pty Ltd was founded in March 2002 in Sydney, Australia. The corporate portal was firstly launched in October 2002. Aspose strives to provide the richest component choices for global .NET programmers. Thousands of organizations from tens of countries have acquired Aspose products, including Microsoft, IBM, PricewaterhouseCoopers, Ernst & Young, DuPont, Hilton Hotels, Reader's Digest, Bank of America, Boeing, Siemens, etc.

Aspose Pty Ltd,
Suite 163, 79 Longueville Road
Lane Cove, NSW, 2066
Australia
Phone: 903.306.1676
Fax: 866.810.9465

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release aspose.cloud Newsletter February 2019: Work with Cloud File Format REST APIs & SDKs here

News-ID: 1564646 • Views: 328

More Releases from Aspose

Read/Write Projects Created using MS Office 365 Project Online Service using .NE …
What's New in this Release? Aspose team is pleased to announce the new release of Aspose.Tasks for .NET 19.2. This release includes support for Microsoft Project Online, MPP files saved with Microsoft Office 365 cloud are supported now. Also fixes few issues reported with the API that further enhance the stability of the API. Aspose.Tasks for .NET API now supports Microsoft Office 365 Project Online Services. Now the users shall
Aspose.Newsletter February 2019: Enhance Productivity using JDK 11 Compatible PD …
Aspose Newsletter for February 2019 has now been published that highlights all the newly supported features offered in the recent releases. It includes information about Enhancing productivity & performance using JDK 11 compatible PDF API, Loading Excel workbook efficiently without loading VBA project, Use latest version of Aspose.PDF for C++ with new codebase changes, Create PST folder hierarchy with string notation, Detect archive-based file format and work with AMF files
Load any HTML with Self-Closing Tags & Convert It to Excel File inside Android A …
What’s new in this release? Aspose development team is pleased to announce the new release of Aspose.Cells for Android via Java 18.12. Depiction of data through HTML page is very common, however this page can be opened in variety of devices including mobiles, tabs and other hand held devices which contain small screens. The size of the columns is defined in “pt” which works in many cases. However there can be
Create a Folder Hierarchy in PST Files using String Notation inside .NET Apps
What's New in this Release? Aspose team is pleased to announce the release of Aspose.Email for .NET 18.12. This release adds an overload to AddSubFolder(string name, bool createHierarchy) and CreatePredefinedFolder(string name, StandardIpmFolder defaultFolder, bool createHierarchy) functions that enable users to create folder hierarchy using string notation as shown in the code example on blog announcement page. By setting the second parameter of AddSubFolder() to true, users can create folder hierarchy using

All 5 Releases


More Releases for API

Tagraxofusp - API Insight, 2018
Tagraxofusp, sold under the brand name of Elzonris, is an Interleukin 3 (IL-3) conjugated truncated diphtheria toxin. It is composed of catalytic and translocation domains of diphtheria toxin fused via Met-His linker to a full-length human IL-3. Download the sample report @ https://www.pharmaproff.com/request-sample/1168 Tagraxofusp was developed by Stemline Therapeutics Inc. and was approved in December 2018, as the first therapy for blastic plasmacytoid dendritic cell neoplasm. This drug achieved approval after
Cabozantinib- API Insight, 2018
Cabozantinib, sold under the brand name of Cabometyx and Cometriq, is used for the treatment of medullary thyroid cancer and a second line treatment for renal cell carcinoma. It is a small molecule inhibitor of the tyrosine kinases c-Met and VEGFR2, and also inhibits AXL and RET. Download the sample report @ https://www.pharmaproff.com/request-sample/1164 Discovered and developed by Exelixis Inc., its side-effects include increased liver enzymes, diarrhea, low calcium, mouth sores, decreased
Tyk API Management v2.3
After months working-out in the gym, the new version of Tyk is ready to flex its muscles.   Tyk v2.3 is twice as fast, leaner, more extendable and is still available for FREE! London, United Kingdom 8th December, 2016. Tyk Technologies is pleased to announce the v2.3 release of Tyk, the popular open-source API Management platform.   Tyk v2.3 builds upon the success of previous releases. The feedback and contributions from Tyk’s thriving open source community, as well as enterprise clients, drove
Telecom API Helps Application Developers to Integrate Various API Services
Telecom API market represents an overall Application Programming Interface (API) services provided by telecom carriers, service providers and aggregators to application developers in order to create mobile applications. Telecom API helps application developers to integrate various services such as payment, voice, SMS and WebRTC into their mobile application. This helps application developers to enhance their customer experience and market their mobile applications among end-users. Telecom API provides many benefits to
Biotech API Surging Worldwide
According to a new research report by RNCOS, entitled “Global Biotech API Market Analysis”, geographies across the world are showing insurgent growth in the biotech API Industry. The US occupied more than half of the share in the global market in 2011, and is the largest producer of biotech APIs. Western European countries occupy around 15% share globally among which, the UK is the largest producer of biotechnology-based APIs. The
Global Biotech API Market Analysis
RNCOS has recently added a new Market Research Report titled, “Global Biotech API Market Analysis” to its report gallery. Biotech APIs contribute a very low share in the global API market with synthetic API’s accounting for majority of the formulations. However, with the revolutionary growth in the biopharmaceutical industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly prospective market in the future. As per our